FDA 483 - Frontier Therapeutics inc. - January 08, 2020

An FDA inspection of Frontier Therapeutics Inc., a medical device initial importer in Buffalo, NY, identified one significant observation. The firm's procedures for corrective and preventive actions (CAPA) were found to be inadequately established. This indicates a deficiency in their quality system regarding problem investigation, corrective action implementation, and effectiveness verification.